SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Astrid-Jane Greenup, Pok Kern Tan, Vi Nguyen, Anne Glass, Scott Davison, Ushmi Chatterjee, Susan Holdaway, Dev Samarasinghe, Kathy Jackson, Stephen A. Locarnini, Miriam T. Levy, Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus, Journal of Hepatology, 2014, 61, 3, 502

    CrossRef

  2. 2
    Hwi Young Kim, Jung-Hwan Yoon, Hyo-Suk Lee, Jae Youn Cheong, Sung Won Cho, Hyoung Doo Shin, Yoon Jun Kim, MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B, Journal of Medical Virology, 2014, 86, 3
  3. 3
    Masahiko Ajiro, Zhi-Ming Zheng, Oncogenes and RNA splicing of human tumor viruses, Emerging Microbes & Infections, 2014, 3, 9, e63

    CrossRef

  4. 4
    Dana D. Byrne, Craig W. Newcomb, Dena M. Carbonari, Melissa S. Nezamzadeh, Kimberly B.F. Leidl, Maximilian Herlim, Yu-Xiao Yang, Sean Hennessy, Jay R. Kostman, Mary B. Leonard, Russell Localio, Vincent Lo Re, Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000–2007, Annals of Epidemiology, 2014, 24, 6, 418

    CrossRef

  5. 5
    Jae Youn Cheong, Hyoung Doo Shin, Yoon Jun Kim, Sung Won Cho, Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection, Journal of Medical Virology, 2013, 85, 5
  6. 6
    Nader Roushan, Mohsen Nasiri Toosi, Alipasha Meysamie, Abdoul-Reza Esteghamati, Homazad Hajrassuliha, Hepatitis B Knowledge Among Iranian Adolescents: A National Survey, Iranian Red Crescent Medical Journal, 2013, 15, 12

    CrossRef

  7. 7
    Shuping Tong, Jisu Li, Jack R Wands, Yu-mei Wen, Hepatitis B virus genetic variants: biological properties and clinical implications, Emerging Microbes & Infections, 2013, 2, 3, e10

    CrossRef

  8. 8
    Dong Hyeon Lee, Yuri Cho, Ji Yeon Seo, Jung Hee Kwon, Eun Ju Cho, Eun Sun Jang, Min-Sun Kwak, Jae Youn Cheong, Sung Won Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Hyo-Suk Lee, Chung Yong Kim, Hyoung Doo Shin, Yoon Jun Kim, Polymorphisms nearInterleukin 28BGene Are Not Associated with Hepatitis B Virus Clearance, Hepatitis B e Antigen Clearance and Hepatocellular Carcinoma Occurrence, Intervirology, 2013, 56, 2, 84

    CrossRef

  9. 9
    Weng Kai Chan, Soek-Siam Tan, Rosmawati Mohamed, Stopping Therapy in HBeAg Negative Disease, Current Hepatitis Reports, 2013, 12, 2, 105

    CrossRef

  10. 10
    Alexander Kuo, Robert Gish, Chronic Hepatitis B Infection, Clinics in Liver Disease, 2012, 16, 2, 347

    CrossRef

  11. 11
    Michelle L. Giles, Kumar Visvanathan, Sharon R. Lewin, Joe Sasadeusz, Chronic Hepatitis B Infection and Pregnancy, Obstetrical & Gynecological Survey, 2012, 67, 1, 37

    CrossRef

  12. 12
    Giuseppe Indolfi, Alessandro Nesi, Massimo Resti, Treatment of chronic hepatitis B and C in children, Future Virology, 2012, 7, 10, 955

    CrossRef

  13. 13
    Brian J. McMahon, Natural History of Chronic Hepatitis B, Clinics in Liver Disease, 2010, 14, 3, 381

    CrossRef

  14. 14
    Y. J. Kim, H. Y. Kim, J. S. Kim, J. -H. Lee, J. -H. Yoon, C. Y. Kim, B. L. Park, H. S. Cheong, J. S. Bae, S. Kim, H. D. Shin, H. -S. Lee, Putative association of transforming growth factor-α polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection, Journal of Viral Hepatitis, 2010, 17, 7
  15. 15
    Maureen M. Jonas, Joan M. Block, Barbara A. Haber, Saul J. Karpen, W. Thomas London, Karen F. Murray, Michael R. Narkewicz, Philip Rosenthal, Kathleen B. Schwarz, Brian J. McMahon, Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options, Hepatology, 2010, 52, 6
  16. 16
    MICHAEL P. CURRY, SANJIV CHOPRA, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  17. 17
    Amelie Plymoth, Simonetta Viviani, Pierre Hainaut, Control of hepatocellular carcinoma through Hepatitis B vaccination in areas of high endemicity: Perspectives for global liver cancer prevention, Cancer Letters, 2009, 286, 1, 15

    CrossRef

  18. 18
    J.F. Rahier, S. Ben-Horin, Y. Chowers, C. Conlon, P. De Munter, G. D'Haens, E. Domènech, R. Eliakim, A. Eser, J. Frater, M. Gassull, M. Giladi, A. Kaser, M. Lémann, T. Moreels, A. Moschen, R. Pollok, W. Reinisch, M. Schunter, E.F. Stange, H. Tilg, G. Van Assche, N. Viget, B. Vucelic, A. Walsh, G. Weiss, Y. Yazdanpanah, Y. Zabana, S.P.L. Travis, J.F. Colombel, European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease, Journal of Crohn's and Colitis, 2009, 3, 2, 47

    CrossRef

  19. 19
    F. Blaine Hollinger, Hepatitis B virus infection and transfusion medicine: science and the occult, Transfusion, 2008, 48, 5
  20. 20
    Jean-Pierre Bronowicki, Idrissia Abdelmouttaleb, Laurent Peyrin-Biroulet, Véronique Venard, Hacène Khiri, Nicodème Chabi, Emile K. Amouzou, Hélène Barraud, Philippe Halfon, Ambaliou Sanni, Marc-André Bigard, Alain Le Faou, Jean-Louis Guéant, Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa, Journal of Hepatology, 2008, 48, 4, 532

    CrossRef

  21. 21
    Guohong Deng, Gangqiao Zhou, Rong Zhang, Yun Zhai, Wenli Zhao, Zehui Yan, Chunqing Deng, Xiaoyan Yuan, Baoyan Xu, Xiaojia Dong, Xiumei Zhang, Xuqing Zhang, Zhijian Yao, Yan Shen, Boqing Qiang, Yuming Wang, Fuchu He, Regulatory Polymorphisms in the Promoter of CXCL10 Gene and Disease Progression in Male Hepatitis B Virus Carriers, Gastroenterology, 2008, 134, 3, 716

    CrossRef

  22. 22
    J.T. Gerlach, B. Müllhaupt, Akute Virushepatitiden, Der Gastroenterologe, 2007, 2, 3, 186

    CrossRef

  23. 23
    Anna S. F. Lok, Brian J. McMahon, Chronic hepatitis B, Hepatology, 2007, 45, 2
  24. 24
    Jae Youn Cheong, Sung Won Cho, Jeong Young Choi, Jung A Lee, Min Ho Kim, Jong Eun Lee, Ki Baik Hahm, Jin Hong Kim, RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 Gene Polymorphisms are not Associated with the Outcome of Hepatitis B Virus Infection: Results from a Large Scale Single Ethnic Population, Journal of Korean Medical Science, 2007, 22, 3, 529

    CrossRef

  25. 25
    H. D. Shin, B. L. Park, H. S. Cheong, J.-H. Yoon, Y. J. Kim, H.-S. Lee, SPP1 polymorphisms associated with HBV clearance and HCC occurrence, International Journal of Epidemiology, 2007, 36, 5, 1001

    CrossRef

  26. 26
    Yoon Jun Kim, Jung-Hwan Yoon, Chung Yong Kim, Lyoung Hyo Kim, Byung Lae Park, Hyoung Doo Shin, Hyo-Suk Lee, IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma, Biochemical and Biophysical Research Communications, 2006, 346, 1, 38

    CrossRef

  27. 27
    Paul H. Hayashi, Adrian M. Di Bisceglie, The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis, Medical Clinics of North America, 2005, 89, 2, 371

    CrossRef

  28. 28
    Guohong Deng, Gangqiao Zhou, Yun Zhai, Shuqing Li, Xuhong Li, Ya Li, Ruifang Zhang, Zhijian Yao, Yan Shen, Boqing Qiang, Yuming Wang, Fuchu He, Association of estrogen receptor α polymorphisms with susceptibility to chronic hepatitis B virus infection, Hepatology, 2004, 40, 2
  29. 29
    Mary Ann Huang, Anna S.F Lok, Natural history of hepatitis b and outcomes after liver transplantation, Clinics in Liver Disease, 2003, 7, 3, 521

    CrossRef

  30. 30
    James S. Edstam, Nyamkhuu Dulmaa, Pagbajabyn Nymadawa, Arslan Rinchin, J. Khulan, Ann Marie Kimball, Comparison of Hepatitis B Vaccine Coverage and Effectiveness among Urban and Rural Mongolian 2-Year-Olds, Preventive Medicine, 2002, 34, 2, 207

    CrossRef

  31. 31
    Xavier Castellsagué, F.Xavier Bosch, Nubia Muñoz, Environmental co-factors in HPV carcinogenesis, Virus Research, 2002, 89, 2, 191

    CrossRef

  32. 32
    Henry L.Y. Chan, Anna S.F. Lok, HEPATITIS B IN ADULTS, Clinics in Liver Disease, 1999, 3, 2, 291

    CrossRef

  33. 33
    S.D. Ahmed, L.E. Cuevas, B.J. Brabin, P. Kazembe, R. Broadhead, F.H. Verhoeff, C.A. Hart, Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women, Journal of Infection, 1998, 37, 3, 248

    CrossRef

  34. 34
    W. J. Edmunds, G. F. Medley, D. J. Nokes, C. J. O'Callaghan, H. C. Whittle, A. J. Hall, Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr, Epidemiology and Infection, 1996, 117, 02, 313

    CrossRef

  35. 35
    MichaelC. Kew, Protective efficacy of hepatitis B vaccination, The Lancet, 1995, 345, 8957, 1065

    CrossRef

  36. 36
    Pierre Coursaget, Didier Leboulleux, Masserigné Soumare, Pierre le Cann, Bernard Yvonnet, Jean-Paul Chiron, Anna-Marie Coll-Seck, Ibrahima Diop-Mar, Twelve-year follow-up study of hepatitis B immunization of Senegalese infants, Journal of Hepatology, 1994, 21, 2, 250

    CrossRef

  37. 37
    M. Fortuin, J. Chotard, A.D. Jack, N.P. Maine, M. Mendy, A.J. Hall, H.M. Inskip, M.O. George, H.C. Whittle, Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation, The Lancet, 1993, 341, 8853, 1129

    CrossRef

  38. 38
    P. COURSAGET, D. LEBOULLEUX, B. YVONNET, M. SOUMARE, P. LE CANN, M. T. DIOP, O. BAO, J. P. CHIRON, A-M. COLL-SECK, I. DIOP-MAR, Hepatitis B virus infection and hepatocellular carcinoma in Senegal: Prevalence and prevention, Journal of Gastroenterology and Hepatology, 1993, 8, S1
  39. 39
    Bengt Jönsson, Bruno Horisberger, Miguel Bruguera, Lukas Matter, Cost-Benefit Analysis of Hepatitis-B Vaccination: A Computerized Decision Model for Spain, International Journal of Technology Assessment in Health Care, 1991, 7, 03, 379

    CrossRef

  40. 40
    Anna S. F. Lok, Ching-Lung Lai, Hau-Tim Chung, Johnson Y. N. Lau, Elsie K. Y. Leung, Loretta S. K. Wong, Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus–related chronic liver diseases, Hepatology, 1991, 13, 5
  41. 41
    S. RAMIA, M. ARIF, Perinatal transmission of hepatitis B virus infection: a recommended strategy for prevention and control. A Review, BJOG: An International Journal of Obstetrics & Gynaecology, 1991, 98, 2
  42. 42
    M. D. YOHANNAN, M. ARIF, S. RAMIA, Aetiology of lcteric Hepatitis and Fulminant Hepatic Failure in Children and the Possible Predisposition to Hepatic Failure by Sickle Cell Disease, Acta Paediatrica, 1990, 79, 2
  43. 43
    Childhood leukaemia: an infectious disease?, The Lancet, 1990, 336, 8729, 1477

    CrossRef

  44. 44
    C.F. Kiire, Hepatitis B infection in sub-Saharan Africa, Vaccine, 1990, 8, S107

    CrossRef

  45. 45
    C.P. Hudson, How AIDS forces reappraisal of hepatitis B virus control in sub-Saharan Africa, The Lancet, 1990, 336, 8727, 1364

    CrossRef

  46. 46
    M. Arif, A.K. Al-Momen, S. Huraib, S. Ramia, Baseline seroepidemiology of hepatitis B virus infection in two Saudi high-risk groups: patients on haemodialysis and patients with congenital bleeding disorders, Transactions of the Royal Society of Tropical Medicine and Hygiene, 1989, 83, 2, 256

    CrossRef

  47. 47
    Susan M. Wheeley, M.J. Tarlow, Elizabeth H. Boxall, Chronic hepatitis B in male and female children of HBsAg carrier mothers, Journal of Hepatology, 1989, 8, 2, 226

    CrossRef

  48. 48
    The Gambia Hepatitis Study Group, HEPATITIS B VACCINE IN THE EXPANDED PROGRAMME OF IMMUNISATION: THE GAMBIAN EXPERIENCE, The Lancet, 1989, 333, 8646, 1057

    CrossRef

  49. 49
    Adele L. Franks, Cynthia J. Berg, Mark A. Kane, Barbara B. Browne, R. Keith Sikes, William R. Elsea, Anthony H. Burton, Hepatitis B Virus Infection among Children Born in the United States to Southeast Asian Refugees, New England Journal of Medicine, 1989, 321, 19, 1301

    CrossRef

  50. 50
    I. Romieu, I. Sow, S. Lu, G. Laroque, M. Prince-David, J. L. Romet-Lemonne, Prevalence of hepatitis B markers among hospital workers in Senegal, Journal of Medical Virology, 1989, 27, 4
  51. 51
    Infectious Agents Transmitted by Transfusion,